These include surgical sutures, staples, handheld surgical equipment, electrosurgical devices, and adhesive materials used to repair and join tissue internally or externally. The growing elderly population increases the risk of developing medical conditions that often require general surgical procedures. Additionally, technical advancements in general surgery devices help perform complex procedures accurately and safely.
The Global General Surgery Devices Market is estimated to be valued at US$ 16.46 BN in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Global General Surgery Devices Market Size are Medtronic Plc, Johnson & Johnson Service; Inc., Conmed Corporation, Integra LifeSciences, Smith & Nephew, Becton, Dickinson and Company (Bd), B. Braun Melsungen Ag, Cadence Inc, Integer Holdings Corporation, Olympus Corporation, Stryker, Boston Scientific Corporation, Erbe Elektromedizin Gmbh and 3M Healthcare.
The increasing volume of general surgeries performed globally presents significant opportunities for medical device manufacturers. Strategic acquisitions and expansions into emerging markets will help companies strengthen their product portfolios and geographic presence. For instance, Medtronic acquired Mazor Robotics in 2018 to expand its surgical robotics business globally.
North America dominates the general surgery devices market owing to rapid technological adoption and a large patient pool undergoing general surgical procedures in the region. However, Asia Pacific is expected to offer lucrative growth opportunities due to growing healthcare investments, rising medical tourism, and increasing focus on expanding healthcare access in China, India, and other developing Asian countries.
Market Drivers:
- Growing geriatric population prone to age-related conditions requiring general surgical procedures boosts market growth.
- Technological advancements allow minimally invasive procedures and improved recovery, increasing surgical devices adoption.
Market Restrain:
- High costs associated with highly advanced and innovative general surgery devices limit widespread adoption in price-sensitive developing markets.
- Stringent regulatory approval processes and infrastructure requirements for new devices increase manufacturing and compliance costs, restricting market growth.
Segment Analysis
The Global General Surgery Devices Market can be segmented into surgical sutures and staplers, handheld surgical devices and electrosurgical devices. The surgical sutures and staplers segment dominated the market in 2024 due to increasing number of surgeries across the globe. Sutures and staplers are used in every surgery to join separated tissues and close wounds after surgery. Hence, the surgical sutures and staplers segment holds the largest market share in the global general surgery devices market.
Global Analysis
Regionally, North America accounted for the largest share of the global general surgery devices market in 2024 owing to factor such as increasing incidences of chronic diseases, developed healthcare infrastructure, growing geriatric population and shift to minimally invasive surgeries. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period due to rising medical tourism, improving healthcare infrastructure and increasing healthcare expenditure in emerging economies such as China and India. Some key players in the global general surgery devices market are Medtronic Plc, Johnson & Johnson Service; Inc., Conmed Corporation, Integra LifeSciences, Smith & Nephew, Becton, Dickinson and Company (Bd), B. Braun Melsungen Ag, Cadence Inc, Integer Holdings Corporation, Olympus Corporation, Stryker, Boston Scientific Corporation, Erbe Elektromedizin Gmbh and 3M Healthcare.
Get More Insights On This Topic: https://www.ukwebwire.com/general-surgery-devices-market-size-share-analysis-2023-2030/
Comments
0 comment